Of the 234 non-RODIN inhibitor-free patients, 220 (94%) were followed for 13 - DHFR inhibitors in non-small cell lung cancer

Of the 234 non-RODIN inhibitor-free patients, 220 (94%) were followed for 13

Of the 234 non-RODIN inhibitor-free patients, 220 (94%) were followed for 13.3 months and 209 (89.3%) for 19.1 months (all brands GSK547 of rFVIII). a … Continue reading Of the 234 non-RODIN inhibitor-free patients, 220 (94%) were followed for 13